Indication

FGFR3 Alteration

1 clinical trial

1 product

Clinical trial

A Phase II, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) Tablet in Adult Patients With Advanced Cholangiocarcinoma

Status: Completed, Estimated PCD: 2024-02-28

Product